Inhibition of medulloblastoma tumorigenesis by the antiproliferative and pro-differentiative gene PC3

Stefano Farioli-Vecchioli1, Mirella Tanori, Laura Micheli

  • 1Institute of Neurobiology and Molecular Medicine, Consiglio Nazionale Ricerche, Via Fosso di Fiorano 64, 00143, Rome, Italy.

Insights

The antiproliferative gene PC3 prevents medulloblastoma development by promoting cerebellar granule cell precursor (GCP) differentiation and controlling cell cycle. PC3 upregulation reduced tumor incidence in mice, indicating its therapeutic potential.

Area of Science:

  • Neuro-oncology
  • Developmental Neuroscience
  • Cancer Biology

Background:

  • Medulloblastoma, a common childhood brain tumor, originates from cerebellar granule cell precursors (GCPs).
  • The antiproliferative gene PC3 (Tis21/BTG2) is crucial for GCPs to transition from proliferation to differentiation during cerebellar neurogenesis.

Purpose of the Study:

  • To investigate whether PC3 can prevent neoplastic transformation of GCPs and medulloblastoma development.
  • To assess the role of PC3 in a mouse model of medulloblastoma characterized by Sonic Hedgehog pathway hyperactivation.

Main Methods:

  • Crossed transgenic mice conditionally expressing PC3 (TgPC3) in GCPs with Patched1 heterozygous (Ptc(+/-)) mice.
  • Analyzed medulloblastoma incidence, preneoplastic abnormalities, GCP proliferation, and differentiation in Ptc(+/-)/TgPC3 mice.
  • Investigated PC3's mechanism of action on cyclin D1 expression and histone modification.

Main Results:

  • Perinatal PC3 upregulation in Ptc(+/-)/TgPC3 mice decreased medulloblastoma incidence by ~40% and reduced preneoplastic lesions.
  • PC3 overexpression normalized cyclin D1 levels, hyperproliferation, and defective differentiation in Ptc(+/-) GCPs.
  • PC3 inhibited cyclin D1 expression via recruitment to its promoter, leading to histone deacetylation; PC3 was downregulated in medulloblastomas.

Conclusions:

  • PC3 acts as a tumor suppressor in medulloblastoma development.
  • PC3 prevents medulloblastoma by controlling cell cycle progression and promoting GCP differentiation.
  • Downregulation of PC3 is implicated in medulloblastoma pathogenesis, suggesting therapeutic potential.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...